Document Type
Article
Publication Date
2025
Publication Title
The American Journal of Bioethics
Publication Title (Abbreviation)
Am. J. Bioethics
Volume
25
Issue
1
First Page
6
Abstract
Research on psychedelic medicines is experiencing a revival. Some clinicians, scientists, and ethicists believe that psychedelics are so different from other treatments that they warrant special consideration in how they are researched, regulated, commercialized, and administered. Others argue that psychedelic medicines show clinical potential, but they should be treated like other medical interventions. In other words, identical standards should apply. This article analyzes whether psychedelic medicines warrant special consideration from a regulatory and ethical perspective.
Recommended Citation
Mason Marks and I. Glenn Cohen,
Psychedelic Medicine Exceptionalism, 25
Am. J. Bioethics
6
(2025),
Available at: https://ir.law.fsu.edu/articles/847